Navigation Links
New Phase IV Clinical Study Indicates LidoSite Provides,Rheumatology Patients Superior Pain Relief

FAIR LAWN, N.J.--(BUSINESS WIRE)--Mar 19, 2007 - Vyteris Holdings (Nevada), Inc. (OTCBB: VYHN), today announced results from a new phase IV "Open Label" clinical study demonstrating that LidoSite, the first FDA approved active patch for dermal analgesia, provided better pain relief to more than 73 percent of patients receiving injections of hyaluronic acid during treatment for osteoarthritis than usual topical analgesics.

"Treatment can be very painful, requiring multiple injections into sensitive joints, with many patients having a difficult time with this pain, leading some to avoid regular treatment," said Dr. Evan Liebowitz, a rheumatologist affiliated with Prospect Medical Office in Midland Park, NJ and Valley Hospital in Ridgewood, NJ. "Patients who avoid regular treatments for rheumatoid arthritis and osteoarthritis risk further loss of articular cartilage in the knee."

The study, involving six study sites and 14 physicians, followed 63 patients over the course of two routine injections of hyaluronic acid for the treatment of osteoarthritis.

During the first treatment, patients either received no local anesthesia or an alternate local anesthesia prior to cannulation or needle puncture. During the second treatment, patients received the LidoSite system, comprised of the LidoSite Patch and the LidoSite Controller. In the study more than 73 percent preferred LidoSite to the treatment used during their first visit. Additionally, the majority of rheumatology physicians surveyed were satisfied with LidoSite, compared to other available treatment options, such as ethyl chloride, lidocaine injections or fluormethane spray.

"This initial study demonstrates the acceptability among patients and rheumatologists for using LidoSite as an effective treatment regime for needle pain for the multiple injections arthritis requires, as well as its potential availability in the doctor's office setting."
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:9/15/2014)... 2014 GenomeDx Biosciences today announced data ... Society for Radiation Oncology (ASTRO) Annual Meeting demonstrate ... a genomic test capable of predicting aggressiveness of ... patient outcomes for prostate cancer patients following surgery. ... published study that demonstrates how Decipher test results ...
(Date:9/15/2014)... -- Patients in today,s changing health care landscape are receiving ... setting versus a hospital. In an effort to stay ... continue to receive high quality medical care; Kaiser Permanente ... medicine residency program. The program,s progressive curriculum will prepare ... even virtual settings. "We are excited ...
(Date:9/15/2014)... N.J. , Sept. 15, 2014 /PRNewswire-iReach/ -- ... , University of South Carolina, submitted a Citizen ... Commissioner, asking the FDA to add another Black ... drug labels.  This request asks for a Black ... "toxic psychoses, hallucinations, paranoia, suicidal thoughts or acts, ...
Breaking Medicine Technology:Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 3Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 2Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 3Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3
... PARSIPPANY, N.J., March 31, 2011 Pacira Pharmaceuticals, Inc. ... company, today announced financial results for the fourth quarter ... on the execution of its pre-commercial and launch strategies ... "Since our initial public offering in February, we have ...
... CardioNexus Corporation ( www.cardionexus.com ) an affiliated ... Panasonic CardioHealth® Station at the 2011 Annual Scientific ... device, which has just received clearance from the ... and portable cardiovascular imaging device which aims to ...
Cached Medicine Technology:Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 2Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 3Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 4Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 5Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 6Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 7Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 8Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 9Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 10Breakthrough CardioHealth® Station Cleared By FDA to Take Center Stage at the Annual Scientific Sessions of the American College of Cardiology 2011 2Breakthrough CardioHealth® Station Cleared By FDA to Take Center Stage at the Annual Scientific Sessions of the American College of Cardiology 2011 3Breakthrough CardioHealth® Station Cleared By FDA to Take Center Stage at the Annual Scientific Sessions of the American College of Cardiology 2011 4
(Date:9/16/2014)... (PRWEB) September 16, 2014 The rapidly ... concern for health plans, employers and PBMs as spending ... of their drug lists. Once a concentrated, patient-specific practice, ... 25 webinar from Atlantic Information Services, Inc. (AIS), ... will offer details of what one leading health ...
(Date:9/16/2014)... San Diego, CA (PRWEB) September 16, 2014 ... a new hydrating lip gloss that true-ly pampers lips from ... your lips satin-smooth all day. , “The creation of true ... were suffering from dry, dehydrated lips no matter what products ... that not only looked great on, but could actually hydrate ...
(Date:9/16/2014)... Triad Semiconductor, Inc. today announced that David ... former President of Linear Technology Corporation was appointed to ... technology and business expertise, and we are delighted that ... Hayden, Triad CEO and chairman. , Mr. Bell brings ... semiconductor experience to Triad's board. From 2008 to 2012, ...
(Date:9/15/2014)... St. Louis, Missouri (PRWEB) September 16, 2014 ... injury lawyers at Carey Danis & Lowe ... Boston Scientific Corp., was found responsible for the injuries ... their bladder sling to treat stress urinary incontinence (SUI). ... that practices defective medical device litigation and personal injury ...
(Date:9/15/2014)... 2014 iFitDress.com, one of the most distinguished ... sapphire evening dresses to its online store. In ... top quality products. They are now provided at very low ... senior spokesman has confidence in the newly unveiled sapphire evening ... by customers from all over the world. Up to now, ...
Breaking Medicine News(10 mins):Health News:Sept. 25 Webinar to Offer Health Plan, Employer Strategies to Control Compounded Medication Costs 2Health News:True Science Cosmetics, LLC Launches True Lipz™ 2Health News:David Bell Joins Triad Semiconductor's Board of Directors 2Health News:Carey Danis & Lowe Reports On $73 Million Boston Scientific Verdict 2Health News:Beautiful Sapphire Evening Dresses Provided By iFitDress.com 2
... trial finds better control of disease when chemo is targeted ... News) -- The number one cancer killer, lung cancer, may ... drugs to tumors with key genetic traits, a new study ... -- found that, overall, 46 percent of patients with stage ...
... ... successfully completed deployment of CellTrak workflow automation and visit compliance solutions. The result ... ... 18, 2010 -- ABC Hospice, Inc, a premier hospice provider in North East Alabama, ...
... , ... Touchstone Products LLC is proud to announce ... quality Infrared Saunas at affordable prices directly to the American Consumer. ... in the privacy of your home. Constructed from the highest ...
... ... in Trilogy Analytical Laboratory , ... Darmstadt, Germany (PRWEB) April 17, 2010 -- R-Biopharm AG, a leading developer ... that the company has purchased a majority ownership position in Trilogy Analytical Laboratory, Inc. ...
... along the U.S.-Mexico border frequently buy over-the-counter oral contraceptives ... and can send a friend to pick up the ... University of Texas campuses and Ibis Reproductive Health. ... there is demand in the United States for over-the-counter ...
... is available in French . , "It is high ... and help people who suffer from this disease," says Dr. Jean ... the Montreal Chest Institute of the MUHC, and lead investigator of ... Centre for Cardiovascular and Pulmonary Research, University of British Columbia. As ...
Cached Medicine News:Health News:Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes 2Health News:Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes 3Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 2Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 3Health News:Touchstone Saunas Goes Online to Provide Premium Quality Infrared Saunas 2Health News:R-Biopharm Group Purchases a Majority Ownership in Trilogy Lab, Expanding US Operations 2Health News:Convenience drives US women to buy over-the-counter contraception in Mexico, study finds 2Health News:MUHC leads pan-Canadian initiative on respiratory disease 2
... custom bars have a large body ... contacts (spaced 3 centimeters center-to-center) to ... repeated cleaning. Polarity indicators are molded ... handle fits our bar electrode styles. ...
... phakic IOL is the first lens of its ... for the reduction or elimination of myopia in ... diopters and in patients aged 21 and over. ... 150,000 procedures performed worldwide, results prove that the ...
... the strongest vacuum force in ... The unit includes a ... plug, footswitch, built-in wheels, retractable ... ring to hold the liquid ...
... technology for the phakic eye, clinically ... quality of vision and visual acuity ... lens is compatible with current cataract ... for the correction of myopia in ...
Medicine Products: